Lucy Oscós Gil

Lucy Oscós Gil has a diverse work experience in the pharmaceutical industry, spanning over several roles and companies. Their most recent position was as the Business Unit Director at Exeltis, starting in 2020. Prior to that, they served as the Business Unit Director at Neolpharma S.A. de C.V from 2018 to 2020. Before joining Neolpharma, they worked as the Business Unit Director at Stendhal Pharma from 2016 to 2018, where they were responsible for the Cardiology, Cardio-Metabolism, Gastro, and Neurosciences business unit. From 2009 to 2016, they held the role of Director of the Osteoarticular/Pain/CNS business unit at Asofarma de Mexico. Prior to that, they worked at UCB Pharma as a Diagnostics Manager from 2007 to 2008. Lucy also has experience at Roche as a Business Unit Manager for Diabetes and as a Product Manager for Syntex. Earlier in their career, they held positions at Janssen Cilag de Mexico, Grisi Hermanos, and SmithKline Beecham Corporation, primarily in product management roles.

Lucy Oscós Gil earned a Licenciatura degree in Business Administration from Universidad de Negocios ISEC in 1988. Lucy then pursued a Maestria degree in Administration, specializing in Finance and Marketing, from Universidad La Salle, A.C. from 1993 to 1995. In 1996-1997, Lucy completed a Diplomado in Strategic Marketing from Universidad Iberoamericana, Ciudad de México. Lucy also holds a Diplomado in Management from Pontificia Universidad Católica Argentina 'Santa María de los Buenos Aires' but the specific duration is not provided. Recently, in 2020-2022, Lucy has been studying at UNIVERSIDAD IEXPRO to obtain a Dra. En Desarrollo Humano degree. It is unclear whether they have completed any degree at FAAP - Fundação Armando Alvares Penteado as the information is not available.